Sandoz International GmbH
Division of Novartis AG
www.sandoz.com
Latest From Sandoz International GmbH
Who’s Hired? Stenico Takes Lead At Sandoz Germany
Sandoz has named Peter Stenico as permanent country head for its German operations. At the same time, Stada has appointed a trio of executives to key roles in Germany, Hovione has announced a new COO, Hikma and Orion have seen board changes and Sanofi’s biosimilars head in China has left the position for a new role.
Market Brief: Sales Of Patches To Treat Neurological Disorders Will See Fastest Growth In Global Transdermal Patch Market
The overall transdermal patch market is expected to grow at a CAGR of 2.4% by 2024. Patches to treat neurological disorders will see the fastest growth while pain-management patches will see the most sales.
String Of Positives Lifts Lupin's Outlook
Tentative FDA approval for Lupin’s arformoterol tartrate inhalation solution and a potential European nod for etanercept are seen aiding the company’s prospects in FY2021. Besides, success in a Phase III trial for secnidazole to treat trichomoniasis bodes well, though manufacturing clearances and continuity will also be closely watched.
Sandoz Matches Teva On US Rifaximin Launch Date
Sandoz has joined a fellow major generics player, Teva’s Actavis, in settling itself out of litigation with Bausch Health over Xifaxan 550mg tablets in the US. The two settlement agreements contain key similarities and differences.
Company Information
- Industry
-
Pharmaceuticals
- Generic Drugs
- Therapeutic Areas
- Cancer
- Cardiovascular
- Dermatology
- Gynecological, Urological
- Immune Disorders
- Infectious & Viral Diseases
- Neurology, Nervous System
- Ophthalmic
- Respiratory, Pulmonary
- Alias(es)
- Sandoz
- Ownership
- Private
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
Germany
-
Germany
-
Western Europe
-
Europe
- Parent & Subsidiaries
-
Novartis AG
- Sandoz International GMBH
-
Sandoz International GmbH
- Azupharma GMBH
- Biochemie GMBH
- Biochemie GmbH
- Ciba-geigy AG
- Durascan Medical Products AS
- Ebewe Pharma GMBH
- Geneva Pharmaceuticals Inc.
- Hexal AG
- Labinca SA
- Lagap Pharmaceuticals Ltd.
- Oriel Therapeutics Inc.
- Sandoz Canada
- Sandoz Chemicals Corp.
- Sandoz Inc.
- Sandoz KK
- Sandoz Nutrition Corp.
- Sandoz Pharma Ltd.
- Sandoz Pharmaceuticals Corp.
- Sandoz Pharmaceuticals Ltd.
- Sandoz Research Institute
- Senior Management
-
Philippe Deecke, CFO
Richard Francis, Division Head
Isabel Afonso, Head, Global Commercial Operations
Shawn Silvestri, Global Head, Product Dev. - Contact Info
-
Sandoz International GmbH
Phone: (49) 8024 4760
Industriestrasse 25
Holzkirchen, D-83607
Germany